MRI study for breast cancer diagnosis and follow-up
Part of Cancer, Skin clinical trials.
This study uses a special type of MRI called diffusion-weighted imaging to help diagnose breast cancer and check on it after treatment. It is for women who have a breast lump or whose breast cancer has returned after chemotherapy or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female
- You are 18 years or older
- You have a breast lump or breast cancer that has come back after treatment
- You do not have a pacemaker or metal aneurysm clips (which are not safe for MRI)
- You have not had a recent injury to the same breast, and you are not breastfeeding with an infection or abscess
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This trial studies using MRI images to help plan and guide radiation therapy after breast-conserving surgery. It may help doctors target the right area more accurately while keeping treatment standard and safe.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.